10/7/22 16:06 | 10/6/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -8 | 1.83 | 0 | -5 | -100 | 0 | D | | | | | | | | | | | | | | |
7/20/22 16:19 | 7/18/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -19 | 2.57 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
4/20/22 16:03 | 4/18/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -21 | 2.83 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
1/20/22 16:33 | 1/18/22 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -31 | 4.07 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
10/20/21 18:56 | 10/18/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -61 | 8.13 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
7/21/21 16:04 | 7/19/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -48 | 6.40 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
4/21/21 16:16 | 4/19/21 | OCGN | Ocugen, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | | S.d | -40 | 5.33 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
2/11/14 20:33 | 2/7/13 | ONTX | Onconova Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Ramesh | PA | DO | P,CEO | S.dm | -506 | 15.07 | 0 | -34 | -11 | 277 | D | | | -50 | 12 | 23 | 4 | -2 | 3 | -4 | -2 | -44 | -60 | -62 | -80 |
2/3/14 20:25 | 1/30/14 | ONTX | Onconova Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Ramesh | PA | DO | P,CEO | S.dm | -903 | 15.05 | 0 | -60 | -18 | 277 | D | | | -31 | -8 | 14 | 26 | 8 | 12 | -3 | 0 | -45 | -63 | -69 | -73 |